Clinical Trial Update: PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a PD-1 antibody after preoperative chemoradiotherapy in locally advanced pMMR/MSS rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma
• Rectal Cancer

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING